SCHEMBL7190830

SCHEMBL7190830

CCCOc1ccc(C(C)(C)C)c(OCCC)c1C=CC(=O)c1ccc(NC)cc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.40
CYP1A1 P04798 2/20 0.40
CYP1B1 Q16678 2/20 0.40
DPP4 P27487 2/20 0.36
TRPV1 Q8NER1 1/20 0.36
MAPT P10636 5/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ATM Q13315 1/20 0.35
CYP3A4 P08684 1/20 0.35
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ABCC1 P33527 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7179792 0.95 ABCG2 (0.42) ABCG2CYP1A1CYP1B1DPP4MAPT
SCHEMBL7182728 0.90 PTPN1 (0.40) ABCG2CYP1A1CYP1B1DPP4MAPT
SCHEMBL7185108 0.89 CYP1A1 (0.42) ABCG2CYP1A1CYP1B1MAPTALDH1A1
SCHEMBL7185112 0.89 CYP1A1 (0.42) ABCG2CYP1A1CYP1B1MAPTALDH1A1
SCHEMBL7796250 0.88 ABCG2 (0.53) ABCG2CYP1A1CYP1B1DPP4MAPT
SCHEMBL7189584 0.87 CA1 (0.42) ABCG2CYP1A1CYP1B1DPP4MAPT
SCHEMBL7184017 0.87 ABCG2 (0.43) ABCG2CYP1A1CYP1B1DPP4MAPT
SCHEMBL7191537 0.85 ABCG2 (0.40) ABCG2CYP1A1CYP1B1DPP4MAPT
SCHEMBL7185258 0.85 PTPN1 (0.41) ABCG2CYP1A1CYP1B1DPP4ABCC1
SCHEMBL7192274 0.84 ABCG2 (0.42) ABCG2CYP1A1CYP1B1DPP4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed